RxSight, Inc. (RXST)

NGM – Real Time Price. Currency in USD

6.95

-0.10 (-1.35%)

Market open: Aug 12, 2026, 10:12 AM EDT

7.04

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

134M

140M

89M

49M

Cost of goods sold

-31M

-41M

-35M

-28M

Gross Profit

103M

99M

54M

21M

Operating expenses (excl. COGS)

-151M

-136M

-104M

-85M

Operating Income

-48M

-37M

-50M

-63M

Non-operating income, total

-3M

Pretax income

-39M

-27M

-49M

-67M

Equity in earnings

Taxes

-66K

-50K

-20K

-9K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-39M

-27M

-49M

-67M

Discontinued operations

Net income

-39M

-27M

-49M

-67M

Dilution adjustment

Preferred dividends

RxSight, Inc. (RXST)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

RxSight, Inc. (RXST)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

RxSight, Inc. (RXST)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

RxSight, Inc. (RXST)

Income Statement (Annual)

Income Statement (Annual)